Jennifer's Shared Resources
NAFLD: Rising Global Health Issue Tied to Metabolic Dysfunction, Gut Microbiome, and Emerging Therapies
Non-alcoholic fatty liver disease (NAFLD) is characterized by ≥5% hepatic steatosis unrelated to alcohol or drug use, primarily driven by...
MASLD: A Growing Global Health Concern Driven by Obesity, Diabetes, and Cardiovascular Risks
The terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) have been replaced by metabolic-dysfunction-associated steatotic liver disease (MASLD)...
Understanding MASH: The Severe Stage of MASLD Linked to Inflammation and Liver Damage
Metabolic dysfunction-associated fatty liver disease (MASLD), previously known as NAFLD or MAFLD, is a liver condition associated with metabolic syndrome...
Patients Share Stories About Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a liver condition unrelated to alcohol consumption but can progress to serious complications like...
Rezdiffra and Noncirrhotic Non-alcoholic Steatohepatitis
The first US Food and Drug Administration-approved medication to treat noncirrhotic non-alcoholic steatohepatitis, otherwise known as NASH, is Rezdiffra (resmetirom)....
New Clinical Practice Update on Nonalcoholic Fatty Liver Disease in Lean Individuals
The American Gastroenterological Association has issued a new clinical practice update focused on the diagnosis, staging, and management of nonalcoholic...